From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
With a growing armamentarium for glaucoma, balancing safety and efficacy is the modern-day challenge
Everything you need to know about SARS-CoV-2 and the COVID-19 pandemic
A round-up of novel coronavirus-related stories
With the pandemic putting frontline health workers under mounting pressure, is it possible for ophthalmologists to safely see patients?
The glaucoma subspecialty is now at a turning point, but new approaches, including MIGS, must be based on high-quality evidence
The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning
Organ-to-cloud technology is here – and it has its sights set on glaucoma
How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease?
Clark E. Tedford tells us about his part in creating LumiThera, its flagship product and technology, and the company’s plans for the future
by Rheon Medical
Rheon Medical’s eyeWatch device offers true pressure control in the surgical management of glaucoma
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.